Thanks, Frank S. David for this! I was going to retire last year, but this new idea to develop nucleic acid mimics of the replicative form of a retrovirus is just too exciting to ignore - link to scientific slides. We're looking to collaborate/partner! dropbox.com/t/xaUU7pQlkdo6…

Join us on Thurs, April 25 for what will be an unforgettable day full of engaging speaker talks, a lively poster session and the unveiling of our first Lifetime Achievement Award. Register now for our 10th anniversary #RNA Medicine Symposium! bit.ly/48CFa0F

Seeking mentorship in oligo research? Look no further! The OTS Mentorship Program is here to connect early career scientists with seasoned professionals from academia and industry. Learn more and apply at oligotherapeutics.org/the-mentorship… #OTS #science #oligoresearchers #sciencecareer

I call on all major medical orgs to stop hosting conferences in states without full #ReproductiveHealthcare access. It's not an ideological or political issue. It is a safety issue for the women & pregnant people attending your conferences. #AbortionIsHealthcare #MedTwitter

Loving Sudhir Agrawal's cover art for Nucleic Acid Therapeutics, cleverly reflecting the decades of work that have brought our field to its current state!

Art Krieg Thank you, Art. I still want to take you on a spectacular bike ride around Appenzell, in due time.

Another great day in the mountains! My first return to Franconia Ridge since my rotator cuff surgery, and feeling great!

Well done, Aaron Ring and the entire Timmerman Traverse team! The money U-Haul have raised already will do a lot of good, proving to the world that Life Science Cares! Life Science Cares

Thanks, Arnav for joining me for a “sunrise” trail run in Noanet Reservation - great way to start the day!

#AnotherGreatDayInTheMountains! My first time back on the presidential traverse since my quadriceps tendon repair and rotator cuff repair, and I’m loving life!

It’s another great day to be in the mountains, the colors in Franconia notch and along Franconia Ridge are amazing!

At the OTS meeting in Montreal, the auditorium broke out in loud applause at today’s news!

Congrats ⁦John Maraganore 🇺🇸🇬🇷🇺🇦⁩ on winning the OTS Lifetime Achievement Award for his incredible leadership building Alnylam, and a new therapeutic siRNA platform! ⁦Oligonucleotide Therapeutics Society⁩

I’m leaving twitter/X too, just disgusted by where it’s gone. Please join me on Bluesky, Art Krieg

Thank you Brad Loncar for the chance to tell how my initial discovery of CpG DNA (TLR9 agonist) 30 yrs ago led to vidutolimod, and how at Zola Therapeutics we've discovered novel RNA/DNA TLR7/8/9 agonists that appear to be a huge leap forward for cancer immunotherapy!

I’m delighted to see these positive data, the first randomized clinical trial performed with vidutolimod, the first CpG-A TLR9 agonist! Great news for patients!

Cancer immunotherapy is complicated, and I've struggled to explain the new science of TLR7/8/9 agonists to non-experts, so I've made this video: A brief history of cancer immunotherapy, for non-immunologists and patients youtu.be/KLgCU5Gm3pA?si… via YouTube

I recently had the pleasure of joining The Pharmaverse Podcast podcast - it released this morning. We discussed the parallels between running marathons (and ultras) and my >30 yrs of efforts activating immunity to fight cancer, culminating in founding Zola Rx youtu.be/FX9MLqv9PBQ

My new review article covers key points I have not seen in any other review of cancer immunotherapy: i) the difference between IFN-a and IFN-b; ii) the unique role of P1 pDC among all DC subsets; iii) the unique role of TLR7/8/9 nam10.safelinks.protection.outlook.com/?url=http%3A%2…

Nucleic acid medicines are transforming patient care, and the pace of this evolution is accelerating: come to this conference to learn more!